1464 studies found for:    alzheimer
Show Display Options
Rank Status Study
41 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
42 Completed Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
43 Completed Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases;   Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
44 Completed
Has Results
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine 5 and 10 cm^2 patch
45 Recruiting A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg /kg;   Drug: BAN2401 5 mg /kg;   Drug: BAN2401 10 mg /kg;   Drug: Placebo
46 Completed Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Condition: Alzheimer Disease
Intervention:
47 Completed A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Other: MRI;   Other: FDG-PET
48 Completed Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Memory Loss;   Cognitive Impairment
Intervention: Drug: ladostigil hemitartrate
49 Recruiting Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: AADvac1
50 Completed Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: atomoxetine hydrochloride;   Drug: placebo
51 Completed
Has Results
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases
Interventions: Drug: EVP-6124 (0.1 mg/day);   Drug: EVP-6124 (0.3 mg/day);   Drug: EVP-6124 (1.0 mg/day);   Drug: Comparator: Placebo;   Drug: Donepezil;   Drug: Rivastigmine
52 Completed Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: placebo
53 Completed
Has Results
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
54 Active, not recruiting Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Other: Observational Study
55 Not yet recruiting 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: AADvac1
56 Completed Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy
Condition: Alzheimer Disease
Intervention: Other: observational
57 Completed European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: HF0220
58 Completed Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia
Conditions: Alzheimer's Disease;   Dementia
Intervention: Device: Blood sampling
59 Completed Randomized Trial of a Nutritional Supplement in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Dietary Supplement: Resveratrol with Glucose, and Malate;   Dietary Supplement: Placebo
60 Recruiting Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Conditions: Early Onset Alzheimer Disease;   Alzheimer Disease;   Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment;   Device: No treatment

Indicates status has not been verified in more than two years